CRISPR and Cancer

Leading epigeneticist Gabriella Ficz has used CRISPR technology to investigate the interplay between DNA methylation and cancer. Her latest findings...

In a recent study, researchers in the U.S. and Australia engineered bacteria that can detect specific extracellular DNA sequences and mutations from...

Beam Therapeutics reports dosing of the first patient with BEAM-201, a multiplex-edited allogeneic CAR-T cell candidate developed to treat relapsed or...

In this clinical trial roundup, we look at ongoing trials of gene-edited therapies for cancers of the gastrointestinal tract.

With no effective treatments available, brain metastases are associated with extremely low survival rates. In their latest work, Khalid Shah’s team at...

AvenCell Therapeutics announces that the European Medicines Agency has approved its clinical trial application for AVC-201, a novel CRISPR-edited and...

Caribou Biosciences has reported positive long-term follow-up data from the dose escalation portion of the ongoing ANTLER Phase 1 trial. The trial is...

New research from Carl June’s lab at University of Pennsylvania may be a game-changer for adoptive T cell immunotherapies: by taking the brakes off T...